Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Çѱ¹ÀÎ ¿©¼º¿¡¼­ ´Ù³¶¼º³­¼ÒÁõÈıºÀÇ ¹ß»ý À§Çèµµ¿Í Catechol-O-Methyltransferase À¯ÀüÀÚ ´ÙÇü¼º°úÀÇ °ü·Ã¼º¿¡ °üÇÑ ¿¬±¸ Association of the COMT Gene Polymorphism with the Risk of PCOS in Korean Women

´ëÇѺÒÀÓÇÐȸÁö 2006³â 33±Ç 2È£ p.97 ~ 104
ÀÌÁö¿µ, Â÷À±Á¤, Ç㼺Àº, ±ÇÇѼº, À̼±ÁÖ, ¼ÕÀμ÷, ±è¼ö³ç, ¼º¿¬¾Æ, Á¤Çý¿ø,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÁö¿µ ( Lee Ji-Young ) 
°Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç

Â÷À±Á¤ ( Cha Yun-Jeong ) 
°Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
Ç㼺Àº ( Hur Sung-Eun ) 
°Ç¾ç´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
±ÇÇѼº ( Kwon Han-Sung ) 
°Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
À̼±ÁÖ ( Lee Sun-Joo ) 
°Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
¼ÕÀμ÷ ( Sohn In-Sook ) 
°Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
±è¼ö³ç ( Kim Soo-Nyung ) 
°Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
¼º¿¬¾Æ ( Sung Yeon-Ah ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Á¤Çý¿ø ( Chung Hye-Won ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç

Abstract

¸ñ Àû: Çѱ¹ÀÎ ¿©¼º¿¡¼­ ¿¡½ºÆ®·Î°ÕÀÇ ´ë»ç ¹× ºÒÈ°¼ºÈ­¿Í °ü·ÃµÈ COMT À¯ÀüÀÚ ´ÙÇü¼º°ú ´Ù³¶¼º³­¼ÒÁõÈıºÀÇ ¹ß»ý À§ÇèµµÀÇ °ü·Ã¼ºÀ» ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.

¿¬±¸¹æ¹ý: ¿¬±¸´ë»óÀÚ´Â 2003³â ESHREÀÇ Áø´Ü ±âÁØÀ» ¸¸Á·ÇÏ´Â ´Ù³¶¼º³­¼ÒÁõÈıº ¿©¼º 136¸í°ú ¿¬·ÉÀÌ ºñ½ÁÇÏ¸ç ±ÔÄ¢ÀûÀÎ »ý¸®¸¦ ÇÏ´Â ¿©¼º 84¸íÀÇ ´ëÁ¶±ºÀ» ´ë»óÀ¸·Î ÇÏ¿´´Ù. ¿¬±¸´ë»óÀÚµéÀÇ genomic DNA´Â Ç÷¾×¿¡¼­ ÃßÃâÇÏ¿´À¸¸ç, PCR ¹× RFLP¸¦ ÀÌ¿ëÇÏ¿© À¯ÀüÀÚ ´ÙÇü¼ºÀ» Á¶»çÇÏ¿´´Ù.

°á °ú: COMT¸¦ ÄÚµùÇÏ´Â À¯ÀüÀÚÀÇ exon4¿¡¼­ G¡æA·ÎÀÇ ´ÙÇü¼ºÀ» Á¶»çÇÑ °á°ú ¿ÀÈ÷·Á ÀúÈ°¼º À¯ÀüÀÚÇüÀÎ COMTLL ±º¿¡¼­ Åë°èÀûÀ¸·Î À¯ÀÇÇÏ°Ô ´Ù³¶¼º³­¼ÒÁõÈıºÀÇ ¹ß»ý À§Çèµµ°¡ ³·¾ÆÁö´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù (OR 0.241(CI 0.114~0.508)).

°á ·Ð: ÀÌ»óÀÇ °á°ú·Î º¼ ¶§ ÀúÈ°¼º À¯ÀüÀÚÇüÀÎ COMTLL ´ÙÇü¼º ±º¿¡¼­ Çѱ¹ÀÎ ´Ù³¶¼º³­¼ÒÁõÈıº ¹ß»ýÀÌ °¨¼ÒÇÏ¿´À¸¸ç, ¿¡½ºÆ®·Î°Õ ÀÇÁ¸Çü ÁúȯÀÌ Áõ°¡ÇÔ¿¡µµ Ç÷Áß ¿¡½ºÆ®¶óµð¿ÃÀÇ ³óµµ°¡ ³ôÁö ¾ÊÀº °ÍÀº ´Ù³¶¼º³­¼ÒÁõÈıº ȯÀÚ¿¡¼­ COMTHH ´ÙÇü¼º±ºÀÌ Áõ°¡µÇ¾î ÀÖ´Â °Í°ú °ü·ÃµÈ °ÍÀ¸·Î »ç·áµÈ´Ù.

Objective: To investigate whether polymorphism of Catechol-O-methyltransferase (COMT) gene is associated with the risk of polycystic ovary syndrome (PCOS) in Korean women.

Methods: One hundred and thirty-six PCOS patients and eighty four controls were enrolled. Blood samples were collected from the patients diagnosed according to the 2003 revised criteria of the Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Age matched women with regular menstruation from same geographic region were recruited as control subject. Polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) of PCR products were done to determine all individuals¡¯ genotype.

Results: In women with COMTLL genotype, there was decreased PCOS risk and this difference was statistically significant (OR 0.24, 95% CI 0.11~0.51).

Conclusion: The results suggest that the COMTLL genetic polymorphism might be associated with PCOS risk in Korean women.

Å°¿öµå

COMT;´Ù³¶¼º³­¼ÒÁõÈıº;À¯ÀüÀÚ ´ÙÇü¼º
COMT;PCOS;Polymorphism

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS